Search

Search Constraints

You searched for: Author/Creator Mathieu Alessandro author non-byline.

Search Results

1. Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials. Issue 5 (24th December 2013)

2. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Issue 4 (16th February 2015)

3. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Issue 7 (31st July 2015)

4. Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study. Issue 1 (27th August 2014)

5. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th April 2019)

6. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study. Issue 7 (9th July 2019)

7. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st June 2019)

8. Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis. Issue 9 (21st September 2019)

9. Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Issue 2 (28th September 2020)

10. Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Issue 5 (11th May 2019)